Pharmacotherapy of alcoholism – an update on approved and off-label medications

@article{Soyka2017PharmacotherapyOA,
  title={Pharmacotherapy of alcoholism – an update on approved and off-label medications},
  author={M. Soyka and C. M{\"u}ller},
  journal={Expert Opinion on Pharmacotherapy},
  year={2017},
  volume={18},
  pages={1187 - 1199}
}
ABSTRACT Introduction: Only a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the latter is licensed for reduction of alcohol consumption only), the putative glutamate receptor antagonist acamprosate and the aldehyde dehydrogenase inhibitor disulfiram. It also covers off-label medications of interest, including topiramate, gabapentin… Expand

Paper Mentions

Interventional Clinical Trial
Alcohol Use Disorders (AUD's) are a major health and social problem. Relapse is a rule rather than an exception in alcohol dependence, leading to poor outcomes. Craving are frequently… Expand
ConditionsAlcohol Use Disorder
InterventionDevice
Pharmacogenetics of alcohol use disorder treatments: an update
Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 235 REFERENCES
Current pharmacological treatment approaches for alcohol dependence
The Status of Disulfiram: A Half of a Century Later
Neuropharmacological treatments for alcoholism: scientific basis and clinical findings
Substitution therapy for alcoholism: time for a reappraisal?
Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature.
...
1
2
3
4
5
...